| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 76.678 | 102.164 | 139.809 | 221.685 | 258.032 | 245.893 | 345.631 | 375.263 |
| Total Income - EUR | - | - | 76.678 | 102.164 | 139.809 | 221.685 | 258.032 | 245.893 | 347.141 | 379.786 |
| Total Expenses - EUR | - | - | 1.535 | 2.009 | 2.893 | 3.842 | 2.220 | 11.087 | 21.339 | 41.489 |
| Gross Profit/Loss - EUR | - | - | 75.144 | 100.155 | 136.916 | 217.844 | 255.813 | 234.806 | 325.802 | 338.297 |
| Net Profit/Loss - EUR | - | - | 72.843 | 97.090 | 133.378 | 211.823 | 248.944 | 232.491 | 322.401 | 327.131 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dorisan Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 3.133 | 2.503 | 4.642 |
| Current Assets | - | - | 74.210 | 98.677 | 134.782 | 214.429 | 251.308 | 231.808 | 323.667 | 335.213 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 8.740 | 6.353 | 87.296 | 160.483 | 182.676 | 190.584 | 253.749 | 240.980 |
| Cash | - | - | 65.470 | 92.324 | 47.486 | 53.946 | 68.632 | 41.224 | 69.918 | 13.820 |
| Shareholders Funds | - | - | 72.887 | 97.142 | 133.429 | 211.873 | 248.993 | 232.539 | 322.449 | 327.180 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.323 | 1.535 | 1.354 | 2.556 | 2.315 | 2.418 | 3.807 | 12.982 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dorisan Med Srl